PT - JOURNAL ARTICLE AU - Hannah Holsinger AU - Anna Blackstock AU - Susan Shaw AU - Sharon L. Roy TI - Evaluation of Residual Disinfectant Levels in Public Drinking Water Distribution Systems in Relation to an <em>Acanthamoeba</em> Keratitis Outbreak—Illinois 2002–2009 AID - 10.1101/2021.08.27.21262491 DP - 2021 Jan 01 TA - medRxiv PG - 2021.08.27.21262491 4099 - http://medrxiv.org/content/early/2021/08/30/2021.08.27.21262491.short 4100 - http://medrxiv.org/content/early/2021/08/30/2021.08.27.21262491.full AB - Acanthamoeba keratitis (AK) is a painful, potentially blinding eye disease associated with contact lens use and corneal injury. AK, caused by the free-living amoeba Acanthamoeba, is ubiquitous in the environment and has been isolated from municipal water supplies. It can be tolerant of normal chlorine levels in drinking water. An AK outbreak investigated in 2003–2005 in five Illinois counties showed a lower AK age-standardized rate ratio in Cook County than in surrounding counties and was hypothesized to be due in part to reductions in residual disinfectant levels (RDLs) in drinking water. We evaluated RDLs in public water systems in the same five Illinois counties over eight years (2002–2009) using a multivariable model of water system RDL measurements. Fitted RDLs for each county were in the acceptable range by United States Environmental Protection Agency standards for the entire study period. After correcting for multiple testing, two of the surrounding counties had fitted RDLs that differed from Cook County for one year—this pattern differed from the epidemiologic pattern of cases observed in the AK outbreak. Our findings do not support the hypothesis that the development of AK was associated with changes in RDLs in the five Illinois counties.Competing Interest StatementThe authors have declared no competing interest.Funding StatementHannah Holsinger conducted the study discussed in this publication as part of her Association of Schools and Programs of Public Health Fellowship at the United States Environmental Protection Agency (U.S. EPA).Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:IRB review was not required for this study, as it was limited to the analysis of environmental data. No information or biospecimens from or about people were collected or used for this analysis. This was confirmed by the Senior Human Subjects Advisor for CDC's National Center for Emerging and Zoonotic Infectious Diseases (NCEZID), who is authorized to determine IRB review requirements and regulatory applicability on behalf of NCEZID.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe data used in this manuscript were obtained from the state of Illinois via EPA's Region 5 office.